HemoRel-A is a 250 IU and 500 IU preparation of clotting factor VIII. HemoRel-A is indicated for replacement of factor VIII in patients, who have factor VIII deficiency i.e. patients diagnosed with haemophilia A. Factor VIII replacement is the therapy of choice for clotting disorder in haemophilia A.